Antioxidative effects of lemon oil and its components on copper induced oxidation of low density lipoprotein

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 10, 2001, Pages 799-805

  Grassmann J ^a   Schneider, D ^a   Weiser, D ^a   Elstner, E F ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antioxidants; Essential oils; Lemon oil, antioxidative effect; Low density lipoprotein, oxidation; Terpenoids; Terpinene

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; COPPER; ESSENTIAL OIL; FLAVONOID; LEMON OIL; LOW DENSITY LIPOPROTEIN; LYCOPENE; TERPENOID; TERPINENE; TRYPTOPHAN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; LIPOPHILICITY; LIPOPROTEIN METABOLISM; MALE; OXIDATION;

EID: 0034778479     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300118     Document Type: Article

References (47)

1. The oxidative modification hypothesis of atherogenesis: An overview
2. Oxidants and antioxidants: An appraisal
3. Beyond cholesterol. Modifications of low density lipoprotein that increase ist atherogenicity
4. Low density lipoprotein oxidation and its pathobiological significance
5. The oxidation of lipoproteins by monocytes-macrophages: Biochemical and biological mechanisms
6. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation
7. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor
8. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
9. Cell-mediated oxidation of low density lipoprotein; the elusive mechanism(s)
10. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex
11. Involvement of 15-lipoxygenase in early stages of atherogenesis
12. Lipoxygenase and atherosclerosis: Protection versus pathogenesis
13. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols
14. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
15. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: Reaction pathways and antioxidant protection
16. Transition metal ions within human atherosclerotic lesions can catalyze the oxidation of low density lipoprotein by macrophages
17. Iron released from transferrin at acidic pH can catalyze the oxidation of low density lipoprotein
18. Molecular mechanisms of the copper dependent oxidation of low density lipoprotein
19. Ceruloplasmin and cardiovascular disease
20. Intact human ceruloplasmin oxidatively modifies low density lipoprotein
21. Identification of the prooxidant site of human ceruloplasmin: A model for oxidative damage by copper bound to protein surfaces
22. Atheroprotective mechanisms of HDL
23. High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis
24. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
25. Effect of antioxidants on oxidative modification of LDL
26. Role of vitamin E in preventing the oxidation of low-density lipoprotein
27. Antioxidative efficacy of parallel and combined supplementation with Coenzyme Q10 and d-α-tocopherol in mildly hypercholesterolemic subjects: A randomized placebo-controlled clinical study
28. Coenzyme Q10, vitamin E, and dihydrothioctic acid cooperatively prevent diene conjugation in isolated low-density lipoprotein
29. Flavonoids as antioxidants
30. Interaction between flavonoids and α-tocopherol in human low density lipoprotein
31. Antioxidant properties of essential oils: Possible explanation for their anti-inflammatory effects
32. Continuos monitoring of in vitro oxidation of human low density lipoprotein
33. Implications of lag time concept in the oxidation of LDL
34. Sensitivity of tryptophane and related compounds to oxidation induced by lipid autoperoxidation. Application to human low- and high-density lipoproteins
35. Early destruction of tryptophane residues of apolipoprotein B is a vitamin E independent process during copper-mediated oxidation of LDI
36. The influence of magnesium-pyridoxal-5′-phosphate-glutamate in comparison with probucol, alpha-tocopherol and trolox on copper-induced oxidation of human low density lipoprotein
37. Desialylation of low density lipoprotein-metabolic function versus oxidative damage?
38. The antioxidative effects of the isoflavane glabridin on endogenous constituents of LDL during its oxidation
39. Biovailability and pharmacokinetics of natural volatile terpenes in animals and humans
40. Uptake, distribution and elimination of α-pinene in man after exposure by inhalation
41. Pharmacokinetics of d-limonene in the rat by GC-MS assay
42. D-limonene exposure to humans by inhalation: Uptake, distribution, elimination and effects on the pulmonary function
43. Human exposure to 3-carene by inhalation: Toxicokinetics, effects on pulmonary function and occurene or irritative and CNS symptoms
44. Radical-scavenging activities of citrus essential oils and their components: Detection using 1,1-diphenyl-2-picrylhydrazyl
45. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro
46. Inhibition of oxidation of human low-density lipoproteins by phenolic substances in different essential oils varieties